Portfolio (Quarterly)
Guide ↗
PROFUND ADVISORS LLC
· CIK 0001129919| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 121 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 22,867.0 | $2.4M | 0.09% | -3K | -10.6% | $105.40 | -5.9% |
| 122 | PAYX | PAYCHEX INC | Industrials | 26,076.0 | $2.4M | 0.09% | -5K | -16.6% | $92.12 | +5.3% |
| 123 | GEV | GE VERNOVA INC | Utilities | 2,706.0 | $2.4M | 0.09% | -58.0 | -2.1% | $872.90 | +19.0% |
| 124 | CYTK | CYTOKINETICS INC | Healthcare | 35,713.0 | $2.4M | 0.09% | -4K | -9.9% | $65.91 | +16.7% |
| 125 | ARM | ARM HOLDINGS PLC | Technology | 15,405.0 | $2.3M | 0.09% | -3K | -16.0% | $151.28 | +102.6% |
| 126 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 47,093.0 | $2.3M | 0.09% | -1K | -2.2% | $49.16 | -2.1% |
| 127 | EXEL | EXELIXIS INC | Healthcare | 53,582.0 | $2.3M | 0.08% | -3K | -6.1% | $42.89 | +16.9% |
| 128 | TJX | TJX COS INC NEW | Consumer Cyclical | 14,328.0 | $2.3M | 0.08% | -2K | -13.4% | $159.70 | -0.9% |
| 129 | — | PRAXIS PRECISION MEDICINES I | — | 7,081.0 | $2.3M | 0.08% | -1K | -16.2% | $322.19 | — |
| 130 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 8,790.0 | $2.3M | 0.08% | -1K | -11.1% | $258.32 | +15.9% |
| 131 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 30,377.0 | $2.3M | 0.08% | -2K | -4.9% | $74.26 | -6.9% |
| 132 | CTSH | COGNIZANT TECHNOLOGY SOLUTIO | Technology | 36,431.0 | $2.2M | 0.08% | -9K | -19.6% | $61.35 | -14.0% |
| 133 | WFC | WELLS FARGO & CO | Financial Services | 27,917.0 | $2.2M | 0.08% | -6K | -17.9% | $79.61 | -4.0% |
| 134 | — | ICICI BANK LIMITED | — | 85,742.0 | $2.2M | 0.08% | -5K | -5.0% | $25.90 | — |
| 135 | BIIB | BIOGEN INC | Healthcare | 11,961.0 | $2.2M | 0.08% | -2K | -15.8% | $183.33 | +5.7% |
| 136 | SRE | SEMPRA | Utilities | 22,269.0 | $2.2M | 0.08% | -10K | -31.3% | $97.17 | -4.5% |
| 137 | INCY | INCYTE CORP | Healthcare | 22,743.0 | $2.1M | 0.08% | -2K | -8.7% | $94.12 | +3.2% |
| 138 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 76,447.0 | $2.1M | 0.08% | -37K | -32.4% | $27.70 | +8.2% |
| 139 | PCVX | VAXCYTE INC | Healthcare | 36,396.0 | $2.1M | 0.08% | -14K | -27.9% | $58.11 | -18.6% |
| 140 | HALO | HALOZYME THERAPEUTICS INC | Healthcare | 32,515.0 | $2.1M | 0.08% | -4K | -9.9% | $64.63 | +5.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
44.0%
Healthcare
11.7%
Communication Services
9.4%
Consumer Cyclical
9.2%
Consumer Defensive
4.9%
Energy
4.8%
Basic Materials
4.7%
Industrials
4.3%
Financial Services
3.7%
Utilities
2.7%